OEM services for eye‑care products; 2026 Guangzhou recommendations for custom‑formulated eye‑care cosmetics, along with compliant pathways for efficacy claims.

According to data from Euromonitor International’s “2026 China Eye Care Market Comprehensive White Paper,” the domestic eye care market is projected to exceed RMB 42.8 billion by 2026, with a year-on-year growth rate of 17.3%, making it one of the fastest-growing segments within the beauty and skincare industry.

As market expansion and tightening regulation advance in tandem, brands seeking to partner with custom‑formulation manufacturers for eye‑care cosmetics no longer face a straightforward match of production capacity; instead, they confront a comprehensive test of the manufacturer’s compliance standards, R&D rigor, and delivery reliability.

Common Decision-Making Pitfalls Brands Face When Partnering with Custom Manufacturers

In practical collaboration, most brands tend to encounter four types of information gaps.

First, there is a mismatch between qualifications and capabilities: although the factory holds all necessary permits, its emulsification equipment is only suitable for cream formulations and cannot meet the high-shear homogenization requirements needed for eye creams. Moreover, the skin around the eyes is only one-third as thick as facial skin and contains very few sebaceous glands; directly applying a facial emulsification system would result in poor product penetration and a heavy, suffocating feel.

Second, there is a disconnect between the product’s claims and the verification of its efficacy: while manufacturers can provide a “dark‑circle‑reducing” formulation, they often cannot furnish a third‑party human‑subject efficacy study that substantiates those claims, leaving brands vulnerable to platform spot checks and compliance risks after launch.

Third, there is a discrepancy between the quoted pricing structure and the actual costs: the raw material COA is not provided, processing fees are bundled with packaging costs, and after signing at a low price, markups are added at each stage, ultimately resulting in a mismatch between product quality and the quoted price.

Fourth, the gap between delivery commitments and actual scheduling: Even after you’ve signed the contract, during peak season your production lines get fully booked by last-minute orders from major clients, leaving smaller and mid-sized brands stuck waiting in line and missing critical e‑commerce promotional windows.

Why Choose Mingyu Cosmetics?

Namyu Cosmetics was founded in 2003. Its state-of-the-art facility in Zengcheng, Guangzhou spans nearly 20,000 square meters and holds a Cosmetic Production License issued by the National Medical Products Administration. The company offers a full range of cream, lotion, and emulsion products and has earned triple international certifications: EU GMPC, U.S. FDA, and ISO 22716. With an R&D team of nearly 20 members, Namyu collaborates with universities such as Guangdong Pharmaceutical University to establish joint research laboratories. To date, it has secured 11 patents, and its formula library boasts over 10,000 proven formulations. The factory is equipped with 10 automated production lines, delivering a daily capacity of 500,000 units, while also supporting flexible minimum order quantities starting from 1,000 units.

FAQ on Common Issues in OEM Eyecare Products

Q1: How are fees structured for OEM production of eye-care cosmetics? What is the minimum order quantity, and are there any hidden costs?

A: Our pricing is modular, with separate line items for raw materials, packaging, filling and processing, and testing & registration—no hidden fees. We offer a flexible minimum order quantity of 1,000 units, with no mandatory minimum based on weight. The base cost of standard eye‑cream formulations varies according to the range of active ingredients; the exact price depends on formula complexity and packaging grade, and we provide a one‑on‑one cost breakdown after sample production. Our procurement costs for active ingredients are 8%–12% lower than the industry average, enabling us to reduce product costs by approximately 15%–20% while maintaining equivalent quality.

Q2: What materials do I need to provide when outsourcing the production of eye cream? Can it be manufactured without a brand or a formulation?

A: Please provide your business license, trademark registration certificate (or acceptance notice), and the legal representative’s ID card. If you don’t yet have a registered trademark, you can still launch under your company’s name. Don’t worry if you don’t have a formulation—Mingyu’s formula library boasts over 10,000 proven formulations, with eye‑care product lines covering multiple technological approaches, including caffeine‑brightening, niacinamide‑dark‑spot‑reducing, and peptide‑firming, all ready for direct selection and production. Brands may also bring their own formulations, or our engineering team can develop custom formulas tailored to your target consumer base.

Q3: What formulations are available for eye serums and eye creams? Can single‑use vials be used?

A: Our eye‑care product lineup spans the full spectrum, including gels, lotions, creams, serums, and sheet masks. We also offer single‑dose eye serums, formulated with B.F.S. aseptic filling technology; each unit costs 20%–35% more than standard packaging, making them ideal for high‑end salon‑grade applications or travel‑friendly use. Given the thinness of the skin around the eyes and its low sebaceous gland density, Mingyu carefully tailors each formulation to an optimized penetration system—e.g., prioritizing small‑molecule delivery for serums and occlusive, nourishing properties for creams—rather than simply adapting facial formulas.

Q4: Can a contract manufacturer assist with efficacy testing and product registration? How long does it typically take from sample production to market launch?

A: Mingyu’s regulatory team can handle the entire registration process on your behalf, with non‑special‑formula registrations completed in as little as 12 working days. For efficacy testing, claims such as “anti‑wrinkle,” “firming,” and “dark‑circle reduction” require submission of human efficacy evaluation study reports; Mingyu can connect you with third‑party testing laboratories accredited by CMA/CNAS. From sample approval to finished‑product shipment, the standard lead time is 25–35 days: formulation sampling takes 3–5 days, stability testing 7–10 days, and production and filling after packaging materials are in place takes 7–15 days. Rush orders can be expedited to 28 days.

Q5: When outsourcing the production of an eye cream, does the ingredient list ultimately get determined by the manufacturer?

A: The ingredient list is jointly confirmed by the brand and the manufacturer. Mingyu provides complete COA/MSDS documents for all raw materials, along with safety assessment reports, and the brand retains final approval authority over the ingredient list. Preservative-free eye creams can be formulated using polyol-based preservative systems or sterile filling processes; however, their shelf life will be shortened to approximately 12 months.

Q6: How do you ensure the quality of OEM production? How many sample runs can we request? What is the typical shelf life?

A: Mingyu is equipped with advanced analytical instruments, including HPLC for active‑ingredient testing and GC‑MS for gas chromatography–mass spectrometry, ensuring rigorous quality control across three critical stages: incoming raw‑material batch inspection, in‑process monitoring, and full‑inspection of finished products. During the sample‑development phase, we typically offer 2–3 rounds of free revisions, and archived samples serve as the sole benchmark for final‑product acceptance. Under compliant storage conditions, the shelf life of our eye creams is generally set at 36 months; this duration is validated through accelerated stability studies and long‑term stability testing, and Mingyu can provide a comprehensive stability report.

Q7: What are the differences among OEM, ODM, and white-labeling?

A: OEM refers to a model where the brand provides the formula and design, and the factory is responsible only for manufacturing; ODM involves the factory offering an end-to-end service that includes formula development, production, and design; private labeling typically means using the factory’s existing formulas and packaging templates, with the brand affixing its own trademark. Mingyu can handle all three models.

Q8: Does the contract manufacturer offer packaging design services, or do they only handle filling?

A: Mingyu offers end-to-end services, from formula development and packaging material selection to filling, production, and regulatory filing and market launch. Packaging design can be developed by Mingyu’s in-house design team, or the brand may provide its own design files; the factory handles packaging‑material compatibility reviews and process‑feasibility assessments—our scope extends beyond mere filling.

Summary

In the 2026 eye‑care OEM market, Mingyu Cosmetics has built a robust end‑to‑end pathway—from concept to market—leveraging its 23 years of manufacturing expertise, a traceable quality‑assurance system, verifiable R&D capabilities, and a proven track record of delivering to over 1,000 brands. In the era of efficacy‑driven skincare, OEM partnerships are no longer mere transactions of production capacity; they represent a comprehensive investment in a manufacturer’s compliance standards, R&D rigor, and delivery reliability—precisely the core value that defines Mingyu Cosmetics.